Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device developed by EMBL scientists. The research, reported in Nature Communications on June 22, marks the latest advancement in the field of personalised medicine.
Using a microfluidic device that fits in the palm of your hand, scientists screened over 1100 treatment conditions (56 drug combinations x 20 replicates) on patient tumour cells. In the future, such tests could be used to inform clinicians on safe and effective combinations of cancer treatments. This research, incorporating fundamental science alongside clinical expertise at Aachen University Hospital, was led by EMBL group leader Christoph Merten and Julio Saez-Rodriguez, former group leader at EMBL-EBI and now Professor at Heidelberg University.
Small biopsies, many drugs
Directly testing multiple cancer drugs on biopsies – parts of the tumour which have been taken from a patient – is a powerful way to discover which drugs work best, and for whom. This is because depending on the specific tumour characteristics, cancer therapies can be more effective in some people than others. However, large-scale patient specific drug screenings have so far been limited by the small biopsy size that can typically be obtained from patients. That is why in the current paper, the team developed a miniaturised device which can test more drugs on a limited number of cells.
The research team initially tested 56 drug combinations on two different human cancer cell types grown in the lab. Drug combinations which killed both types of cancer cells were thought to be potentially toxic and thus unsafe for further testing. However, some drug combinations which targeted and killed only one type of cancer cell were found to be more effective than standard clinical therapies which only use one drug. These results were highly reproducible and could be validated in mouse models of human cancer.
Subsequently, cells from four cancer patient biopsies were applied to the microfluidic device and different drug combinations were tested. “We found that each individual cancer responded best to a different combination of drugs, highlighting the urgent need for patient-specific therapies,” says Federica Eduati, joint first author on the paper alongside Ramesh Utharala who designed and developed the microfluidic device.
“Before we transfer this technology into the clinics, we need to repeat these experiments in larger-scale mouse studies to understand which types of cancer this technology works best in,” says Christoph Merten. “Still, this is an exciting ‘proof of principle’ collaboration between scientists and clinicians, and we have shown that these tests can be run quickly and for less than $150 USD per patient.”
Receive an email update when we add a new PERSONALIZED MEDICINE article.
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Purdue researchers develop smarter, more personalized medicine to aid glaucoma patients on November 12, 2018 at 1:18 pm
Researchers at Purdue drain issues with glaucoma treatment devices. (We) created a new drainage device that combats (the) problem of buildup,” Hyowon Lee, an assistant professor in the School of Biome... […]
- Immunoassay Instruments Market Fueled by Rising Demand for Personalized Medicine on November 12, 2018 at 12:39 pm
Albany, NY -- (SBWIRE) -- 11/12/2018 -- Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platfo... […]
- Opinion: Lower health care costs with personalized medicine on November 12, 2018 at 9:12 am
One and a half million Americans suffer from rheumatoid arthritis. The autoimmune disease is far more severe than regular arthritis – it can destroy the cartilage around bones, resulting in physical d... […]
- Research brings personalized medicine to treat leukemia one step closer on November 12, 2018 at 8:03 am
Bone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: Wikipedia Scientists at the University of Birmingham have revealed the roles that different types of ... […]
- Giant leap toward personalized medicine helps eyes drain themselves on November 10, 2018 at 5:56 pm
Researchers created a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyesight. Purdue University researchers have invent... […]
- AI in drug development and personalized medicine on November 9, 2018 at 10:09 am
Medicine and other scientific areas have always used computing power wherever they could find it-- to help modeling go faster and arrive at viable drugs more quickly. But when we apply the most ... […]
- Purdue's giant leap toward personalized medicine helps eyes drain themselves on November 8, 2018 at 1:36 pm
The Purdue University glaucoma drainage device is built with microactuators that vibrate when a magnetic field is introduced. Credit: Hyowon Lee/Purdue University Purdue University researchers ... […]
- Purdue’s giant leap toward personalized medicine helps eyes drain themselves for glaucoma patients on November 8, 2018 at 11:07 am
WEST LAFAYETTE, Ind. – Purdue University researchers have invented a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyes... […]
- Hebrew University and Yissum Developing Novel Technology Platform for 3D Printing Personalized Medicine on November 8, 2018 at 1:14 am
Yissum, which is the Hebrew University of Jerusalem‘s technology transfer company and handles the patenting and commercialization of any inventions produced there, has had a hand in many unique ... […]
via Bing News